A detailed history of Victory Capital Management Inc transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 122,228 shares of PCRX stock, worth $2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
122,228
Previous 87,639 39.47%
Holding current value
$2 Million
Previous $2.51 Million 26.61%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$11.7 - $28.46 $404,691 - $984,402
34,589 Added 39.47%
122,228 $1.84 Million
Q2 2024

Aug 05, 2024

BUY
$25.5 - $31.51 $351,288 - $434,081
13,776 Added 18.65%
87,639 $2.51 Million
Q1 2024

May 03, 2024

BUY
$27.7 - $35.48 $229,882 - $294,448
8,299 Added 12.66%
73,863 $2.16 Million
Q4 2023

Feb 05, 2024

SELL
$26.32 - $34.31 $82,197 - $107,150
-3,123 Reduced 4.55%
65,564 $2.21 Million
Q3 2023

Nov 06, 2023

SELL
$30.68 - $40.09 $44,363 - $57,970
-1,446 Reduced 2.06%
68,687 $2.11 Million
Q2 2023

Jul 27, 2023

BUY
$36.12 - $47.5 $85,496 - $112,432
2,367 Added 3.49%
70,133 $2.81 Million
Q1 2023

May 02, 2023

BUY
$35.53 - $43.38 $113,305 - $138,338
3,189 Added 4.94%
67,766 $2.77 Million
Q4 2022

Feb 10, 2023

BUY
$38.19 - $57.45 $109,376 - $164,536
2,864 Added 4.64%
64,577 $2.49 Million
Q4 2022

Feb 09, 2023

SELL
$38.19 - $57.45 $470,118 - $707,209
-12,310 Reduced 16.63%
61,713 $2.38 Million
Q3 2022

Nov 02, 2022

BUY
$51.24 - $58.89 $450,143 - $517,348
8,785 Added 13.47%
74,023 $3.94 Million
Q2 2022

Aug 01, 2022

SELL
$51.49 - $81.64 $313,007 - $496,289
-6,079 Reduced 8.52%
65,238 $3.8 Million
Q1 2022

May 04, 2022

SELL
$60.03 - $76.49 $201,460 - $256,700
-3,356 Reduced 4.49%
71,317 $5.4 Million
Q4 2021

Feb 07, 2022

BUY
$47.97 - $62.21 $139,065 - $180,346
2,899 Added 4.04%
74,673 $4.49 Million
Q3 2021

Nov 02, 2021

BUY
$54.64 - $61.3 $158,893 - $178,260
2,908 Added 4.22%
71,774 $4.02 Million
Q2 2021

Aug 03, 2021

SELL
$59.18 - $69.99 $899,121 - $1.06 Million
-15,193 Reduced 18.07%
68,866 $4.18 Million
Q1 2021

May 04, 2021

BUY
$59.31 - $78.82 $3.98 Million - $5.29 Million
67,140 Added 396.83%
84,059 $5.89 Million
Q4 2020

Feb 01, 2021

SELL
$50.47 - $66.26 $45,069 - $59,170
-893 Reduced 5.01%
16,919 $1.01 Million
Q3 2020

Nov 09, 2020

BUY
$51.97 - $63.0 $264,475 - $320,607
5,089 Added 40.0%
17,812 $1.07 Million
Q2 2020

Aug 07, 2020

BUY
$30.8 - $52.47 $25,071 - $42,710
814 Added 6.84%
12,723 $668,000
Q1 2020

May 04, 2020

BUY
$28.4 - $50.7 $2,556 - $4,563
90 Added 0.76%
11,909 $399,000
Q4 2019

Feb 06, 2020

BUY
$36.31 - $46.83 $31,807 - $41,023
876 Added 8.01%
11,819 $535,000
Q4 2019

Feb 04, 2020

BUY
$36.31 - $46.83 $76,178 - $98,249
2,098 Added 23.72%
10,943 $473,000
Q3 2019

Nov 12, 2019

BUY
$35.66 - $44.99 $315,412 - $397,936
8,845 New
8,845 $337,000

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $750M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.